Detailed price information for Harvest Eli Lilly High Income Shares ETF (LLYH-T) from The Globe and Mail including charting and trades.

Algernon to Acquire NoBrainer - Plans to Establish Alzheimer's Diagnostic and Treatment Medical Clinics Featuring New PET Scan Technology ...

"We are introducing Wegovy (injectable Semaglutide 2.4 mg) this year, which offers full therapeutic strengths of semaglutide ...

CAMPBELL, Calif. (AP) — CAMPBELL, Calif. (AP) — 8x8 Inc. (EGHT) on Monday reported a loss of $5.4 million in its fiscal fourth quarter. On a per-share basis, the Campbell, California-based company ...

Drugmaker Novo Nordisk expects Wegovy weight-loss drug sales in the United States to start to recover once a ban on compound copycats is enforced this month, its CEO said on Wednesday after the ...

Looking ahead, Wall Street forecasts adjusted EPS of $23.21 for fiscal 2025, representing a 78.7% increase from $12.99 in ...

She has also worked at Discover Financial Services, Burson-Marsteller, Golin and Hill & Knowlton. In Q4, Eli Lilly posted revenue of $13.5 billion, driven by demand for Zepbound and Mounjaro, up 45% ...

Eli Lilly also posted a 90 bps improvement in gross margin to 83.2% in Q4. Higher revenues clubbed with margin expansion resulted in earnings of $5.32 per share, up over 2x from the $2.49 figure ...

Eli Lilly Q4 Presentation In Q4 2024, Eli Lilly's revenue grew 45%, driven by Mounjaro and Zepbound, the company's core weight-loss drugs. Non-incretin revenue grew by 20% compared to Q4 2023.

Mike, please go ahead. Good morning, thank you for joining us for Eli Lilly and Company's Q4 2024 earnings call. I'm Mike Czapar, Senior Vice President of Investor Relations. Joining me on today's ...

Eli Lilly (NYSE: LLY) stock inched 2.5% higher through 9:50 a.m. ET Thursday after beating on the top and bottom lines in ...

INDIANAPOLIS (AP) — INDIANAPOLIS (AP) — Eli Lilly and Co. (LLY) on Thursday reported fourth-quarter earnings of $4.41 billion. The Indianapolis-based company said it had profit of $4.88 per share.